Breaking News

NorthStar Medical Radioisotopes Enters Clinical Supply Pact

NorthStar to provide large-scale U.S. manufacturing of both the therapeutic isotope (Cu-67) and cGMP radiopharmaceutical product.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

NorthStar Medical Radioisotopes, LLC, a global provider of radiopharmaceuticals used to detect and treat cancer and other serious diseases, has signed a Clinical Supply Agreement with Clarity Pharmaceuticals for the production of 67Cu-SAR-bisPSMA drug product for Clarity’s Phase I/II and Phase III trials. The overarching Master Service agreement and associated Clinical Supply Agreement are effective immediately and the initial production of supply to support Clarity trials is expected to occur b...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters